Management des Prolaktinoms vor, während und nach der Schwangerschaft

Autor: Stephan Petersenn

Publikováno v: DMW - Deutsche Medizinische Wochenschrift. 148:371-379

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b250d87075dee4fa51e2a4e64a9fe091
https://doi.org/10.1055/a-1847-2500

Initial pathology in aggressive pituitary tumours and carcinomas: 2b or not 2b?-that is the question

Autor: Jacqueline Trouillas, Pia Burman, Marco Losa, Ann McCormack, Stephan Petersenn, Vera Popovic, Marily Theodoropoulou, Olaf M Dekkers, Gerald Raverot

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a4c861f301a9b3a49880721508af16d
https://hdl.handle.net/1887/3619444

Predictive factors for responses to primary medical treatment with lanreotide autogel 120 mg in acromegaly: post hoc analyses from the PRIMARYS study

Autor: Caroline Sert, Philippe Caron, Stephan Petersenn, Aude Houchard

Publikováno v: Pituitary

Purpose PRIMARYS (NCT00690898) was a 48-week, open-label, phase 3b study, evaluating treatment with the somatostatin receptor ligand lanreotide autogel (stable dose: 120 mg/28 days) in treatment-naïve patients with growth hormone (GH)-secreting pitu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa1e9cf66b6106f39468705ef8383f0b
https://doi.org/10.1007/s11102-019-01020-3

Management of Aggressive Pituitary Tumors – A 2019 Update

Autor: Stephan Petersenn

Publikováno v: Hormone and Metabolic Research. 51:755-764

With a prevalence of 80–100/100000, pituitary adenomas are more frequent than thought. The rare aggressive pituitary adenoma presents a special challenge, due to the heterogenous presentation of the disease. The prognosis of aggressive pituitary ad

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e76653ab65af7f081e6dcf2cd72dd99
https://doi.org/10.1055/a-1060-1883

Consensus on Diagnosis and Management of Cushing’s Disease: A Guideline Update

Autor: Stylianos Tsagarakis, Ashley B. Grossman, André Lacroix, Maria Chiara Zatelli, Hershel Raff, Lynnette K. Nieman, Eliza B Geer, Cesar Luiz Boguszewski, Beverly M. K. Biller, Marily Theodoropoulou, Mark E. Molitch, Daniel F. Kelly, Alberto M. Pereira, Marcello D. Bronstein, Brooke Swearingen, Stephan Petersenn, Irina Bancos, Adriana G. Ioachimescu, Frederic Castinetti, Ken K. Y. Ho, Ilan Shimon, Martin Reincke, Susan M. Webb, Richard J. Auchus, John Newell-Price, Roberto Salvatori, Shlomo Melmed, Carla Scaroni, Maria Fleseriu, Ursula B. Kaiser, Greisa Vila, Jérôme Bertherat, Anat Ben-Shlomo, Andrea Giustina, Mônica R. Gadelha, Michael Buchfelder, James W. Findling, Mark Gurnell, Rosario Pivonello, Philippe Chanson, Yutaka Takahashi, John A.H. Wass, Nienke R. Biermasz, Ann McCormack, Niki Karavitaki, Felipe F. Casanueva, Laurence Katznelson, Elena Valassi, Antoine Tabarin, John D. Carmichael, Pietro Mortini, Constantine A. Stratakis, Elena V. Varlamov

Publikováno v: Lancet Diabetes Endocrinol
Lancet Diabetes & Endocrinology
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
The Lancet Diabetes and Endocrinology, 9(12), 847-875. ELSEVIER SCIENCE INC

Summary Cushing's disease requires accurate diagnosis, careful treatment selection, and long-term management to optimise patient outcomes. The Pituitary Society convened a consensus workshop comprising more than 50 academic researchers and clinical e

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b02c984bd7cbf20d049ef42e0bca6d7
https://europepmc.org/articles/PMC8743006/